Lipid droplets as protein sequestration sites

脂滴作为蛋白质隔离位点

基本信息

  • 批准号:
    10653248
  • 负责人:
  • 金额:
    $ 38.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Project summary Lipid droplets are the intracellular sites for fat storage, with essential functions in lipid metabolism and energy storage. They also have a second major role in controlling the fate of specific proteins, namely mediating their maturation, transport, refolding, storage, and turnover. While there has been great progress in unraveling how droplets control lipid metabolism, studies of their protein-handling roles remain limited. The goal of this project is to dissect the mechanism, regulation, and physiological relevance of this protein handling function, by taking advantage of the best characterized example of this phenomenon, the sequestration of histone H2Av to lipid droplets in Drosophila ovaries and embryos. H2Av is dynamically stored, exchanging constantly between lipid droplets via the cytoplasm. Lipid droplet sequestration prevents H2Av degradation in oocytes and its premature import into nuclei in embryos. It is also developmentally regulated, being switched off in embryos at the mid- blastula transition. Progress in the last granting period identified the importins Impa2 and Ipo9 as critical factors mediating H2Av exchange, uncovered a correlation between the activity of the cell cycle kinase Cdk1, the phosphorylation state of Impa2, and the rate of H2Av exchange, and discovered that excess nuclear H2Av dramatically alters the transcriptome. These insights led to new models about the mechanism of H2Av exchange, its regulation, and its biological role, models that the current application proposes to test. It is hypothesized that Impa2 promotes H2Av exchange by physically interacting with Jabba and reducing its affinity to H2Av and that Ipo9 acts as cytoplasmic chaperone, accompanying H2Av on its journey between LDs. This model will be tested by determining intracellular distribution and dynamics of the two importins in ovaries and embryos and by analyzing how mutants in key functional domains affect H2Av exchange. To understand the developmental regulation, point mutants in Impa2 will be generated to prevent or mimic phosphorylation and Cdk1 activity will be inhibited. The consequences of these manipulations for H2Av exchange and the physical interactions between importins, the H2Av anchor Jabba, and H2Av will be determined. In nurse cells lacking Jabba, absence of sequestration results in increased levels of nuclear H2Av. Using RNA seq analysis, manipulation of H2Av dosage, and Jabba mutants unable to bind H2Av, it will be determined whether the altered H2Av levels result in changes to the transcriptome. If successful, these studies will test key predictions about the mechanism, regulation, and function of H2Av sequestration by lipid droplets and develop general paradigms for how protein handling by lipid droplets can control processes elsewhere in the cell. These studies will thus provide the groundwork for determining if and how protein sequestration by lipid droplets contributes to their prominent roles in health and disease.
项目摘要 脂质液滴是脂肪储存的细胞内部位,具有脂质代谢和能量的重要功能 贮存。他们在控制特定蛋白质的命运方面也有第二个主要作用,即介导其 成熟,运输,重新折叠,存储和营业额。虽然在解散如何取得了进步 液滴控制脂质代谢,对其蛋白质处理作用的研究仍然有限。这个项目的目标 是通过服用该蛋白质处理功能的机制,调节和生理相关性 这种现象的最佳特征示例的优势,组蛋白H2AV固结至脂质 果蝇卵巢和胚胎中的液滴。 H2AV是动态存储的,在脂质之间不断交换 通过细胞质的液滴。脂质液滴固换可防止卵母细胞中的H2AV降解及其过早 进口到胚胎中的核。它也受到发展的调节,在中间的胚胎中关闭 囊泡过渡。在最后一个授予期内的进展将Importins Impa2和IPO9确定为关键 介导H2AV交换的因素,发现了细胞周期激酶CDK1的活性之间的相关性, Impa2的磷酸化状态和H2AV交换的速率,发现过多的核H2AV 极大地改变了转录组。这些见解导致有关H2AV机制的新模型 交换,调节及其生物学作用,当前应用建议测试。这是 假设Impa2通过与Jabba进行物理相互作用并减少了H2AV交换 与H2AV的亲和力和IPO9充当细胞质伴侣,并伴随着H2AV的旅程 LDS。该模型将通过确定两个进口蛋白的细胞内分布和动力学来测试 卵巢和胚胎以及通过分析关键功能域中的突变体如何影响H2AV交换。到 了解发育法规,将产生Impa2中的点突变体以预防或模仿 磷酸化和CDK1活性将受到抑制。这些操纵对H2AV的后果 Expertins,H2AV锚Jabba和H2AV之间的交换和物理相互作用将是 决定。在缺乏jabba的护士细胞中,缺乏隔离会导致核H2AV水平升高。 使用RNA SEQ分析,H2AV剂量的操纵和无法结合H2AV的JABBA突变体,它将是 确定改变的H2AV水平是否导致转录组发生变化。如果成功,这些研究 将测试有关脂质液滴对H2AV隔离的机制,调节和功能的关键预测 并开发一般的范式,用于如何控制脂质液滴的蛋白质处理能够控制其他地方的过程 细胞。因此,这些研究将为确定是否以及如何通过 脂质液滴在健康和疾病中起着重要作用。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Visualizing Cytoskeleton-Dependent Trafficking of Lipid-Containing Organelles in Drosophila Embryos.
Visualizing Lipid Droplets in Drosophila Oogenesis.
果蝇卵子发生过程中脂滴的可视化。
Sequestration to lipid droplets promotes histone availability by preventing turnover of excess histones.
脂滴的隔离通过防止过量组蛋白的周转来促进组蛋白的可用性。
  • DOI:
    10.1242/dev.199381
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Stephenson,RoxanA;Thomalla,JonathonM;Chen,Lili;Kolkhof,Petra;White,RogerP;Beller,Mathias;Welte,MichaelA
  • 通讯作者:
    Welte,MichaelA
Lipid droplet motility and organelle contacts.
Lipid droplet functions beyond energy storage.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL Andreas WELTE其他文献

MICHAEL Andreas WELTE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL Andreas WELTE', 18)}}的其他基金

Immune-induction of lipid droplets in Drosophila larval hemocytes
果蝇幼虫血细胞脂滴的免疫诱导
  • 批准号:
    10319625
  • 财政年份:
    2020
  • 资助金额:
    $ 38.27万
  • 项目类别:
Lipid droplets as protein sequestration sites
脂滴作为蛋白质隔离位点
  • 批准号:
    8503058
  • 财政年份:
    2013
  • 资助金额:
    $ 38.27万
  • 项目类别:
Lipid droplets as protein sequestration sites
脂滴作为蛋白质隔离位点
  • 批准号:
    8642196
  • 财政年份:
    2013
  • 资助金额:
    $ 38.27万
  • 项目类别:
Lipid droplets as protein sequestration sites
脂滴作为蛋白质隔离位点
  • 批准号:
    8811138
  • 财政年份:
    2013
  • 资助金额:
    $ 38.27万
  • 项目类别:
Lipid droplets as protein sequestration sites
脂滴作为蛋白质隔离位点
  • 批准号:
    9381218
  • 财政年份:
    2013
  • 资助金额:
    $ 38.27万
  • 项目类别:
Lipid droplets as protein sequestration sites
脂滴作为蛋白质隔离位点
  • 批准号:
    9016559
  • 财政年份:
    2013
  • 资助金额:
    $ 38.27万
  • 项目类别:
Lipid droplets as sites for protein sequestration
脂滴作为蛋白质隔离位点
  • 批准号:
    7362100
  • 财政年份:
    2007
  • 资助金额:
    $ 38.27万
  • 项目类别:
Lipid droplets as sites for protein sequestration
脂滴作为蛋白质隔离位点
  • 批准号:
    7502162
  • 财政年份:
    2007
  • 资助金额:
    $ 38.27万
  • 项目类别:
Developmental control of organelle transport
细胞器运输的发育控制
  • 批准号:
    6543386
  • 财政年份:
    2002
  • 资助金额:
    $ 38.27万
  • 项目类别:
Developmental control of organelle transport
细胞器运输的发育控制
  • 批准号:
    7104819
  • 财政年份:
    2002
  • 资助金额:
    $ 38.27万
  • 项目类别:

相似国自然基金

基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
  • 批准号:
    62302456
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
  • 批准号:
    62371403
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于深度学习预测小分子与人类突变激酶结合亲和力的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
反复非平衡结合联合迭代筛选发掘混合物中痕量高亲和力配体的方法及其应用
  • 批准号:
    82273900
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
全新从头快速设计靶向COVID-19病毒及其突变株S蛋白超高亲和力阻断结合蛋白研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目

相似海外基金

Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
  • 批准号:
    10752555
  • 财政年份:
    2024
  • 资助金额:
    $ 38.27万
  • 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 38.27万
  • 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
  • 批准号:
    10724152
  • 财政年份:
    2023
  • 资助金额:
    $ 38.27万
  • 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
  • 批准号:
    10759808
  • 财政年份:
    2023
  • 资助金额:
    $ 38.27万
  • 项目类别:
Unraveling how Lipophilic Modulators Alter pLGIC Function via Interactions with the M4 Transmembrane Helix
揭示亲脂性调节剂如何通过与 M4 跨膜螺旋相互作用改变 pLGIC 功能
  • 批准号:
    10785755
  • 财政年份:
    2023
  • 资助金额:
    $ 38.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了